98 results found

In a decision released publicly on June 21, 2018, the Federal Court dismissed Apotex's action against Shire seeking a declaration of invalidity with respect to Canadian Patent No. 2,527,646.

The Federal Court recently held an individual guilty of contempt of court for disobeying an interlocutory injunction prohibiting the sale of pre-loaded set-top boxes designed to grant...

In the continuing saga between broadcasters and set-top boxes, the Federal Court of Appeal handed a group of Canadian broadcasters a temporary victory in their fight against TVAddons.

Alcon then brought a motion to have Actavis' claims under the Statues of Monopolies struck as premature.

On June 30, 2017, the Supreme Court of Canada released its judgment in AstraZeneca v. Apotex, a case dealing with the utility requirements under the Canadian Patent Act.

Needless to say, the issue of the standard of review applicable to orders of both judges and prothonotaries has been one of the most contentious issues before our Court and before all courts of appeal, including before the Supreme Court of Canada, in the last 10 to 15 years.

The United States Court of Appeals for District of Columbia Circuit affirmed the decision of the District Court for District of Columbia and denied an application for copyright...

The technology at issue relates to torque anchors for oil pumps. Sufficient pressure is required to extract the oil from the earth, which can be generated using a subterranean pump.

On April 11, 2017 the Federal Court of Appeal released its decision in BMS' appeal of a Judgment dismissing a prohibition application relating the drug atazanavir and Canadian Patent No. 2,317,736.

In this copyright infringement action, GE Renewable Energy Canada Inc. (GEREC) sought to make further amendments to its Amended Statement of Claim. The Federal Court allowed the motion in part, emphasizing that amendments must yield a sustainable pleading.

As discussed in a previous post, the Competition Tribunal dismissed JAMP's application against Janssen alleging abuse of dominance in relation to Stelara, Janssen's drug containing the active ingredient ustekinumab.

In Google v. Equustek, the Supreme Court of Canada today upheld a worldwide interlocutory injunction requiring Google to delist certain webpages from its search results.

As part of its obligations under the Canada-European Union Comprehensive Economic and Trade Agreement which came into force on September 21, 2017, ...

On February 26, 2025, the Patent Appel Board was scheduled to hear submissions whether Canadian Patent Application No. 3,137,161 can comply with the formalities of the Patent Act and Rules.

As the parties had already reached agreement regarding matters of liability and quantification of damages, the trial only concerned Millennium's claim for infringement of three patents and Teva's defences based on non-infringement and invalidity.